• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.09% Nasdaq Down 1.53%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    2.70 Down 0.07(2.53%) 10:44AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.77
    Open:2.67
    Bid:2.69 x 600
    Ask:2.70 x 1400
    1y Target Est:12.00
    Beta:1.55323
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:2.60 - 2.75
    52wk Range:2.60 - 9.37
    Volume:656,294
    Avg Vol (3m):2,324,760
    Market Cap:338.56M
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OREXDown 2.53%338.56M
    ABTDown 2.43%65.86B
    GSKDown 3.00%95.96B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.48
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.65
    Quarterly EPS Est (Sep-15) :-0.15
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback